Abstract
A systematic approach to the estimation of bioavailability using both model-independent and pharmacokinetic techniques is introduced. The methods of Kwan-Till and Wagner-Nelson or Loo-Riegelman are integrated such that one is able to check many of the assumptions inherent in these techniques and make appropriate adjustments for apparent deviations. The proposed integrated method makes use of all available data (both plasma and urine) and leads to a better understanding of the absorption, distribution, metabolism, and excretion of the drug being studied.
Similar content being viewed by others
Abbreviations
- A(t) :
-
Cumulative amount of drug absorbed at timet
- C p(t) :
-
Plasma concentration at timet
- C T(t) :
-
Amount of drug in the tissue compartment divided by the volume of the central compartment
- D :
-
Dose of drug administered
- F :
-
Fraction of dose absorbed unmetabolized
- f :
-
Fraction ofF · D excreted unchanged in the urine
- U (t) :
-
Cumulative amount of drug excreted in the urine at timet
- X T :
-
Amount of drug in the tissue compartment
- δ :
-
Observed terminal slope for a one-compartment open model following nonintravascular drug administration
- ɛ :
-
Observed slope on the residuals (estimate of the fast rate constant)
- β :
-
Observed slow disposition rate constant for a two-compartment open model
- k a :
-
First-order absorption rate constant
- k e :
-
Elimination rate constant, one-compartment open model
- k 13 :
-
Elimination rate constant, two-compartment open model
- 12, k21 :
-
Distribution rate constants, two-compartment open model
- V d :
-
Apparent volume of distribution, one-compartment open model
- V 1 :
-
Apparent volume of distribution of the central compartment for a two-compartment open model
- Vcl,r :
-
Renal clearance of drug
- Vcl,p :
-
Plasma clearance of drug
- iv:
-
Drug administered intravenously
- niv:
-
Drug administered by a nonvascular route
- ′:
-
Corrected on the basis of renal component of elimination alone
- ″:
-
Corrected on the basis of proportional changes in renal and nonrenal components of elimination
- *:
-
Calculated by equation 22
- W-N:
-
Wagner-Nelson
- L-R:
-
Loo-Riegelman
- K-T:
-
Kwan-Till
References
J. G. Wagner and E. Nelson. Percent absorbed time plots derived from blood level and/or urinary excretion data.J. Pharm. Sci. 52:610–611 (1963).
J. C. K. Loo and S. Riegelman. New method for calculating the intrinsic absorption rate of drugs.J. Pharm. Sci. 57:918–928 (1968).
A. Rescigno and G. Segre.Drug and Tracer Kinetics, Blaisdell, Waltham, Mass., 1966, pp. 189–195.
L. Z. Benet and C.-W. N. Chiang. The use and application of deconvolution methods in pharmaceutics. InAbstracts of the 13th National Meeting of the APhA Academy of Pharmaceutical Sciences, Chicago, Vol. 2, Washington, D.C., 1972, pp. 169–171.
C. M. Metzler.A Users Manual for NONLIN, Technical Report 7292/69/7292/005, The Upjohn Company, Kalamazoo, Mich., November 25, 1969.
M. Berman and M. F. Weiss.Users Manual for SAAM, National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, Bethesda, Md., 1967.
K. C. Kwan and A. E. Till. Novel method for bioavailability assessment.J. Pharm. Sci. 62: 1494–1497 (1973).
J. G. Wagner and J. I. Northam. Estimation of volume of distribution and half-life of a compound after rapid intravenous injection.J. Pharm. Sci. 56:529–531 (1967).
S. Riegelman, J. C. K. Loo, and M. Rowland. Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.J. Pharm. Sci. 57:117–123 (1968).
K. C. Kwan, D. A. Wadke, and E. L. Foltz. Pharmacokinetics of phosphonomycin in man. I. Intravenous administration.J. Pharm. Sci. 60:678–685 (1971).
L. Z. Benet. General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics.J. Pharm. Sci. 61:536–541 (1972).
Guidelines for Biopharmaceutical Studies in Man, APhA Academy of Pharmaceutical Sciences, Washington, D.C., 1972, pp. 13–14.
J. C. K. Loo. Pharmacokinetic methods of assessing drug absorption: Evaluation and the application of kinetic methods in the investigation of bioavailability of solid oral dosage forms. Thesis, University of California, San Francisco, 1971, pp. 15–18.
Author information
Authors and Affiliations
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/BF01066924.
Rights and permissions
About this article
Cite this article
Till, A.E., Benet, L.Z. & Kwan, K.C. An integrated approach to the pharmacokinetic analysis of drug absorption. Journal of Pharmacokinetics and Biopharmaceutics 2, 525–544 (1974). https://doi.org/10.1007/BF01070946
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01070946